Development And In Vivo Evaluation Of Immediate Release Amlodipine Besylate And Nebivolol Hydrochloride Coated Pellets Using 32 Full Factorial Design By Novel Liquid Layering Technology
Keywords:
Amlodipine besylate, Nebivolol HCl, pellets, liquid layering technique, bioavailability studiesAbstract
The aim of the present investigation was to development of immediate release liquid coated pellets of poorly soluble drugs Amlodipine besylate (AMD) and Nebivolol HCl (NBV) by novel liquid layering technology to enhance solubility and bioavailability with HPC-EF as hydrophilic polymer and PVP K 30 as binder. A 32 full factorial design was employed to optimize the formulation of pellets. In order to optimize formulations, two polymers HPC-EF and PVP K 30 as factors and amount of polymers (three different concentrations), were taken as independent variables. All the formulations were evaluated for particle size, friability, moisture content, drug content, in vitro dissolution studies and in vivo bioavailability studies. All the formulations were found uniform with respect to all evaluation parameters. The optimized formulation (F5) showed highest % of drug release 99.59 by the end of 8 min for AMD and 99.21 % of drug release for NBV, when compared with the marketed product (NEBISTAR-AM) the percentage of AMD and NBV was 83.91 and 82.67 respectively within 8 min, by using 4% of HPCEF and 1% of PVP K 30. SEM confirmed that F5 was spherical in shape with a smooth surface. In vivo studies indicated significant difference in the bioavailability between AMD and NBV coated pellets with pure drug. Clinical data confirmed that the optimized formulation (F5) by choosing immediate release drug coated pellet technology by liquid layering method could improve patient compliance and ensure better disease management when compared with the marketed product.
References
Ammar HO, Salama HA, Ghorab M, Mahmoud AA. Formulation and biological evaluation
of glimepiride–cyclodextrin–polymer systems. Int J Pharm. 2006; 309 (1–2):129–138.
Frick A, Moller H, Wirbitzki E. Biopharmaceutical characterization of oral immediate release drug products. In vitro/in vivo comparison of phenoxymethylpenicillin potassium, glimepiride and levofloxacin. Eur J Pharm Biopharm. 1998; 46 (3):305–311.
Elaine M, Merisko-Liversidge, Gary G. Liversidge. Drug Nanoparticles: Formulating Poorly Water-Soluble Compounds, Toxicol Pathol. 2008; 36(1): 43-48.
Bhanu Prasad M, Vidyadhara S, Sridhar C, Talamanchi Balakrishna, Pavuluri Trilochani. Development and evaluation of diltiazem hydrochloride controlled-release pellets by fluid bed coating process. J Adv Pharm Technol Res. 2013; 4(2): 101–107.
Ghebre-Sellassie I, Pellets: A general overview. In Ghebre-Sellassie Pharmaceutical Pelletization Technology. I (ed.), Vol. 37, Marcel Dekker, Inc., New York, USA, 1989, 1-13.
Scheff E H. Experiments with mixtures. J Royal Stat Soc Ser B, 20, 1958, 344–360.
Mohamed Raffick M, Muthu Mohamed J, Vetriselvan S, Vignesh M, Selvakumar K, Parkavi V, Joysa Ruby J. Preparation and evaluation of in-vitro release kinetics of novel bilayer metoprolol succinate as sustained release and amlodipine besylate as immediate release tablets. Int J of Biol & Pharma Res. 2012; 3(2): 284-296.
Suresh Kumar P, Srikanth B, Satyanarayana T, Shaji G, Navaneetha Krishnan S, Saranya P. Formulation and evaluation of nebivolol mucoadhesive buccal tablet, Pharmacol online. 2011; 869-885.
Hubert M, Sarsfield B, Shekunov B, Grosso J. Oral solid dosage form: from choice of particle size technique to method development and validation. Am. Pharm Rev, 2008; 11(6), 14-23.
Mihir K Raval, Riddhi V Ramani, Navin R Sheth. Formulation and evaluation of sustained release enteric-coated pellets of budesonide for intestinal delivery, International Journal of Pharmaceutical Investigation. 2013; 3 (4): 203-211.
Amtun Noor, Sathesh Babu PR, Aravind P. Formulation Development and In Vitro Evaluation of Immediate Release Fenofibrate Pellets. Asian J Comple & Alternative Med. 2014; 02 (03): 01-06.
Bhanu Prasad M, Vidyadhara S, Trilochani P. Development and evaluation of diltiazem hydrochloride controlled-release pellets by fluid bed coating process. J Adv Pharm Technol Res. 2013, 4(2): 101-107.
Tiwari SB, Murthy TK, Pai RM, Mehta PR, Chowdary PB. Controlled Release Formulation of Tramadol Hydrochloride Using Hydrophilic and Hydrophobic Matrix System, AAPS PharmSciTech. 2003; 4(3): 18-23.
Rajesham VV, Rajyalakshmi G, Reddy AN, Shekar, Anbu J. Effect of Nifedipine on the Pharmacodynamic Parameters of Simvastatin in Hyperlipidemic rats. J of Phar Res. 2009; 2(4): 642-643.
Rajesham VV, Rajyalaxmi G, Anbu J, simultaneous determination of simvastatin and nifedipine in rat plasma by high performance liquid chromatography and pharmacokinetic studies, Pharmacologyonline. 2008; 3:346-353.
Sharma D, Jain A, Shrivastava A. Simultaneous Estimation of Amlodipine Besylate, Nebivolol Hydrochloride In Tablet Dosage Form By Reverse Phase High Performance Liquid Chromatographic Using Ultraviolet Detection. Pharm Methods. 2011; 2(1): 9–14.
